Screening for human ADME/Tox drug properties in drug discovery

Drug Discovery Today

Volumn 6, Issue 7, 2001, Pages 357-366

  Li, Albert P ^a  

^a In Vitro Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; KETOCONAZOLE; PHENYLPROPANOLAMINE; TERFENADINE;

DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TOXICITY; HUMAN; REVIEW;

EID: 0035313896     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01712-3     Document Type: Review

References (25)

1. Managing the discovery/development interface
2. Success rates for new drugs entering clinical testing in the United States
3. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs
4. Warnings based on non-sedating antihistamines terfenadine and astemizole
5. Pharmaceutical applications of cell culture: an overview
6. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
7. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
8. The human hepatic cytochromes P450 involved in drug metabolism
9. Isolation and culturing of hepatocytes from human liver
10. Optimization of cryopreservation procedures for rat and human hepatocytes
11. Cryopreserved human hepatocytes: characterization of DME activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential
12. Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler
13. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and non-specific binding to microsomes
14. Fluorometric high-throughput screening for inhibitors of cytochrome P450
15. Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience
16. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
17. Use of the nuclear receptor PXR to predict drug interactions
18. Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions
19. Effects of cytochrome P450 inducers on 17-alpha-ethinylestradiol (EE2) conjugation by primary human heptocytes
20. Primary hepatocytes as an in vitro toxicological system
21. A high-throughput screening assay for hepatotoxicity using cryopreserved animal and human hepatocytes
22. Ethionine toxicity in vitro: the correlation of data from rat hepatocyte suspensions and monolayers with in vivo observations
23. A fluorometric method for determination of oxidized and reduced glutathione in tissues